炎症性贫血的诊治进展(4)
[14] Solomon， S.D.， et al.， Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med， 2010. 363(12)： p. 1146-55.[15] Jelkmann， W.， et al.， The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol， 2008. 67(1)： p. 39-61.
[16] Nairz， M.， et al.， Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways. Immunity ......
您现在查看是摘要页，全文长 3413 字符。